FDA Inspection 1139663 — David S. Hong, M.D.
The FDA completed an inspection of David S. Hong, M.D. on Mar 25, 2021 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 25, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional details
Clinical Investigator (CI)